Diversity of gut Bifidobacterium species is not altered between allergic and non-allergic French infants

Anaerobe

Volumn 17, Issue 3, 2011, Pages 91-96

  Waligora Dupriet, A J ^a   Campeotto, F ^a,b   Romero, K ^a   Mangin, I ^d   Rouzaud, G ^a   Menard O ^a   Suau, A ^d   Soulaines, P ^b   Nicolis, I ^a   Kapel, N ^a,c   Dupont, C ^b,e   Butel, M J ^a  

^a FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d University of Paris Cité   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Allergy; Bifidobacterium; BOX PCR; Diversity; Infants

Indexed keywords

ANTIBIOTIC AGENT; CALGRANULIN; DNA 16S; GENOMIC DNA; RNA 16S;

AEROBIC BACTERIUM; ALLERGY; ANAEROBIC BACTERIUM; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM ANGULATUM; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM DENTIUM; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM PSEUDOCATENULATUM; CHILD; CLINICAL ARTICLE; CONSULTATION; CONTROLLED STUDY; DELIVERY; DENATURING GRADIENT GEL ELECTROPHORESIS; DISEASE ASSOCIATION; DNA FINGERPRINTING; ETHNIC GROUP; FECES MICROFLORA; FRENCH LANGUAGE; HUMAN; INFANT; INFANT FEEDING; INTESTINE FLORA; MICROBIAL DIVERSITY; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL;

BIFIDOBACTERIUM; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FECES; FRANCE; GASTROINTESTINAL TRACT; HUMANS; HYPERSENSITIVITY; INFANT; LEUKOCYTE L1 ANTIGEN COMPLEX; LOGISTIC MODELS; POLYMERASE CHAIN REACTION; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S;

BIFIDOBACTERIUM;

EID: 79960327640     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2011.04.003     Document Type: Article

References (40)

1. Noverr M.C., Huffnagle G.B. The 'microflora hypothesis' of allergic diseases. Clin Exp Allergy 2005, 35:1511-1520.
2. Moreau M.C., Gaboriau-Routhiau V. Influence of resident intestinal microflora on the development and functions of the Gut-Associated Lymphoid Tissue. Microbiol Ecol Health Dis 2001, 13:65-86.
3. Penders J., Stobberingh E.E., van den Brandt P.A., Thijs C. The role of the intestinal microbiota in the development of atopic disorders. Allergy 2007, 62:1223-1236.
4. Ventura M., van S.D., Fitzgerald G.F., Zink R. Insights into the taxonomy, genetics and physiology of bifidobacteria. Antonie van Leeuwenhoek 2004, 86:205-223.
5. Watanabe S., Narisawa Y., Arase S., Okamatsu H., Ikenaga T., Tajiri Y., et al. Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol 2003, 111:587-591.
6. Bjorksten B. The gastrointestinal flora and the skin-Is there a link?. Pediatr Allergy Immunol 2001, 12(Suppl. 14):51-55.
7. Mah K.W., Bjorksten B., Lee B.W., Van Bever H.P., Shek L.P., Tan T.N., et al. Distinct pattern of commensal gut microbiota in toddlers with eczema. Int Arch Allergy Immunol 2006, 140:157-163.
8. Sepp E., Julge K., Mikelsaar M., Bjorksten B. Intestinal microbiota and immunoglobulin E responses in 5-year-old Estonian children. Clin Exp Allergy 2005, 35:1141-1146.
9. Murray C.S., Tannock G.W., Simon M.A., Harmsen H.J., Welling G.W., Custovic A., et al. Fecal microbiota in sensitized wheezy and non-sensitized non-wheezy children: a nested case-control study. Clin Exp Allergy 2005, 35:741-745.
10. Penders J., Stobberingh E.E., Thijs C., Adams H., Vink C., van R.R., et al. Molecular fingerprinting of the intestinal microbiota of infants in whom atopic eczema was or was not developing. Clin Exp Allergy 2006, 36:1602-1608.
11. Songjinda P., Nakayama J., Tateyama A., Tanaka S., Tsubouchi M., Kiyohara C., et al. Differences in developing intestinal microbiota between allergic and non-allergic infants: a pilot study in Japan. Biosci Biotechnol Biochem 2007, 71:2338-2342.
12. Ouwehand A.C., Isolauri E., He F., Hashimoto H., Benno Y., Salminen S. Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol 2001, 108:144-145.
13. He F., Ouwehand A.C., Isolauri E., Hashimoto H., Benno Y., Salminen S. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol 2001, 30:43-47.
14. Sjogren Y.M., Jenmalm M.C., Bottcher M.F., Bjorksten B., Sverremark-Ekstrom E. Altered early infant gut microbiota in children developing allergy up to 5 years of age. Clin Exp Allergy 2009, 39:518-526.
15. Gore C., Munro K., Lay C., Bibiloni R., Morris J., Woodcock A., et al. Bifidobacterium pseudocatenulatum is associated with atopic eczema: a nested case-control study investigating the fecal microbiota of infants. J Allergy Clin Immunol 2008, 121:135-140.
16. Stsepetova J., Sepp E., Julge K., Vaughan E., Mikelsaar M., De Vos W.M. Molecularly assessed shifts of Bifidobacterium ssp. and less diverse microbial communities are characteristic of 5-year-old allergic children. FEMS Immunol Med Microbiol 2007, 51:260-269.
17. Medina M., Izquierdo E., Ennahar S., Sanz Y. Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications. Clin Exp Immunol 2007, 150:531-538.
18. Menard O., Butel M.J., Gaboriau-Routhiau V., Waligora-Dupriet A.J. Gnotobiotic mouse immune response induced by Bifidobacterium sp. strains isolated from infants. Appl Environ Microbiol 2008, 74:660-666.
19. Butel M.J., Roland N., Hibert A., Popot F., Favre A., Tessèdre A.C., et al. Clostridial pathogenicity in experimental necrotising enterocolitis in gnotobiotic quails and protective role of bifidobacteria. J Med Microbiol 1998, 47:391-399.
20. Ferraris L., Aires J., Waligora-Dupriet A.J., Butel M.J. New selective medium for selection of bifidobacteria from human feces. Anaerobe 2010, 16:469-471.
21. Jousimies-Somer H., Summanen P., Citron D.M., Baron E.J., Wexler H.M., Finegold S.M. Wadsworth-KTL Anaerobic Bacteriology Manual 2002, Star Publishing Compagny, Belmont, California.
22. Mangin I., Suau A., Magne F., Garrido D., Gotteland M., Neut C., et al. Characterization of human intestinal bifidobacteria using competitive PCR and PCR-TTGE. FEMS Microbiol Ecol 2006, 55:28-37.
23. Kok R.G., de W.A., Schut F., Welling G.W., Weenk G., Hellingwerf K.J. Specific detection and analysis of a probiotic Bifidobacterium strain in infant feces. Appl Environ Microbiol 1996, 62:3668-3672.
24. Butel M.J., Suau A., Campeotto F., Magne F., Aires J., Ferraris L., et al. Conditions of bifidobacterial colonization in preterm infants: a prospective analysis. J Pediatr Gastroenterol Nutr 2007, 44:577-582.
25. Mullie C., Odou M.F., Singer E., Romond M.B., Izard D. Multiplex PCR using 16S rRNA gene-targeted primers for the identification of bifidobacteria from human origin. Fems Microbiol Lett 2003, 222:129-136.
26. Masco L., Huys G., Gevers D., Verbrugghen L., Swings J. Identification of Bifidobacterium species using rep-PCR fingerprinting. Syst Appl Microbiol 2003, 26:557-563.
27. Coudeyras S., Marchandin H., Fajon C., Forestier C. Taxonomic and strain-specific identification of the probiotic strain Lactobacillus rhamnosus 35 within the Lactobacillus casei group. Appl Environ Microbiol 2008, 74:2679-2689.
28. Rugtveit J., Fagerhol M.K. Age-dependent variations in fecal calprotectin concentrations in children. J Pediatr Gastroenterol Nutr 2002, 34:323-324.
29. Kalach N., Rocchiccioli F., de Boissieu D., Benhamou P.H., Dupont C. Intestinal permeability in children: variation with age and reliability in the diagnosis of cow's milk allergy. Acta Paediatr 2001, 90:499-504.
30. McFarland L.V., Brandmarker S.A., Guandalini S. Pediatric Clostridium difficile: a phantom menace or clinical reality?. J Pediatr Gastroenterol Nutr 2000, 31:220-231.
31. Brazier J.S. The epidemiology and typing of Clostridium difficile. J Antimicrob Chemother 1998, 41(Suppl C):47-57.
32. Fallani M., Rigottier-Gois L., Aguilera M., Bridonneau C., Collignon A., Edwards C.A., et al. Clostridium difficile and Clostridium perfringens species detected in infant faecal microbiota using 16S rRNA targeted probes. J Microbiol Methods 2006, 67:150-161.
33. Adlerberth I., Strachan D.P., Matricardi P.M., Ahrne S., Orfei L., Aberg N., et al. Gut microbiota and development of atopic eczema in 3 European birth cohorts. J Allergy Clin Immunol 2007, 120:343-350.
34. Matsuki T., Watanabe K., Tanaka R., Fukuda M., Oyaizu H. Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol 1999, 65:4506-4512.
35. Kleessen B., Bunke H., Tovar K., Noack J., Sawatzki G. Influence of two infant formulas and human milk on the development of the faecal flora in newborn infants. Acta Paediat 1995, 84:1347-1356.
36. Magne F., Hachelaf W., Suau A., Boudraa G., Mangin I., Touhami M., et al. A longitudinal study of infant faecal microbiota during weaning. FEMS Microbiol Ecol 2006, 58:563-571.
37. Young S.L., Simon M.A., Baird M.A., Tannock G.W., Bibiloni R., Spencely K., et al. Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood. Clin Diagn Lab Immunol 2004, 11:686-690.
38. Suzuki S., Shimojo N., Tajiri Y., Kumemura M., Kohno Y. Differences in the composition of intestinal Bifidobacterium species and the development of allergic diseases in infants in rural Japan. Clin Exp Allergy 2007, 37:506-511.
39. Matto J., Malinen E., Suihko M.L., Alander M., Palva A., Saarela M. Genetic heterogeneity and functional properties of intestinal bifidobacteria. J Appl Microbiol 2004, 97:459-470.
40. Zeuthen L.H., Christensen H.R., Frokiaer H. Lactic acid bacteria inducing a weak interleukin-12 and tumor necrosis factor alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with gram-negative bacteria. Clin Vaccine Immunol 2006, 13:365-375.